Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06718686 · ClinicalTrials.gov registry record · Phase 1
Rifaximin SSD in Dementia Trial
A Phase 1 study of Dementia Alzheimer Type and Dementia Associated With Cerebrovascular Disease, sponsored by Jasmohan Bajaj.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06718686: Recruiting Phase 1 study of Dementia Alzheimer Type and Dementia Associated With Cerebrovascular Disease, sponsored by Jasmohan Bajaj.
NCT06718686 is a Phase 1 study of Dementia Alzheimer Type and Dementia Associated With Cerebrovascular Disease that is actively recruiting participants, run by Jasmohan Bajaj. The registered enrollment target is 20 participants, below the 73-participant average among 8 other Dementia Alzheimer Type trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06718686, a Phase 1 study of Dementia Alzheimer Type and Dementia Associated With Cerebrovascular Disease, is actively recruiting participants, sponsored by Jasmohan Bajaj.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Rifaximin SSD 40 mg IR tablet
Study Locations (1)
Virginia
- Richmond VA Medical Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-30 |
| Est. Completion | 2026-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06718686
The ClinicalTrials.gov registry entry for NCT06718686 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 73-participant average among 8 other Dementia Alzheimer Type trials with a reported enrollment target (73% lower). The listed sponsor is Jasmohan Bajaj, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dementia Alzheimer Type appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06718686 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06718686 about?
NCT06718686 is a clinical study titled "Rifaximin SSD in Dementia Trial". Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably.
What is the current status of trial NCT06718686?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2024-12-30. Estimated completion is 2026-05.
What conditions does trial NCT06718686 study?
This clinical trial studies the following conditions: Dementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease.
What interventions are being tested in trial NCT06718686?
The interventions under investigation include: Placebo (DRUG), Rifaximin SSD 40 mg IR tablet (DRUG).
Who is sponsoring clinical trial NCT06718686?
This trial is sponsored by Jasmohan Bajaj, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06718686 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia Alzheimer Type
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
RECRUITING · Phase 1
-
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
RECRUITING
-
University of Central Florida Music Study
RECRUITING · NA
-
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
RECRUITING · NA
-
Studies of Brain and Body Interaction
RECRUITING
-
Multi-Center Study of Sensory Stimulation to Improve Brain Function
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Dementia Alzheimer Type
All registered trials for this condition
Dementia Associated With Cerebrovascular Disease
All registered trials for this condition
Virginia
All trials with a study site in Virginia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.